Plasma <i>AR</i> Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
Gianmarco Leone(CRUK Lung Cancer Centre of Excellence), Francesco Orlando(University of Trento), Claire Duggan, Neil McPhail(Cancer Research UK), Ashwin Sachdeva(University of Manchester), Yari Ciani(University of Trento), John Edwards, Bleddyn Edwards, Mahesh Parmar(University College London), Osvaldas Vainauskas(CRUK Lung Cancer Centre of Excellence), Anna Wingate(CRUK Lung Cancer Centre of Excellence), Nicholas D. James(Royal Marsden NHS Foundation Trust), Abigail Hynes, Emily Grist(The University of Adelaide), Sarah Jones, Helen Tench, Donna Robson, Elin Jones, Geraint Morgan(The Open University), Heather McGuinness, Joe M. O’Sullivan(San Antonio College), Sajid Durrani, Thiagarajan Sreenivasan(United Lincolnshire Hospitals NHS Trust), Matthew R. Sydes(MRC Clinical Trials Unit at UCL), L. Strange, Noel W. Clarke(The Christie NHS Foundation Trust), Emma Nurse, Basharat Jameel, Francesca Demichelis(University of Trento), Sharanpreet Lall(CRUK Lung Cancer Centre of Excellence), Christine Kotonya, Sean Thomas, Louise Brown(North Manchester General Hospital), Peter Dutey‐Magni(MRC Clinical Trials Unit at UCL), Daniel Wetterskog(CRUK Lung Cancer Centre of Excellence), Ronda Loosley, Philip Jones, Suparna Thakali(CRUK Lung Cancer Centre of Excellence), R. Canavan, Christian Smith, Mark Narain, Kirsty Marie Dennet, Gerhardt Attard(London Cancer), Toby Frederick Trugeion-Smith
Cited by 5
Related Papers
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
|New England Journal of Medicine|2013|3.3k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k